3 Marijuana Stocks That Could Help Improve Your Portfolio
Right now is another pivotal time for marijuana stocks and the industry as a whole. With more changes entering the space, this will impact how companies operate and how shareholders invest and trade. Cannabis has recently been rescheduled to a class 3 subtance. This change is historic for legal operators in the USA. As well, this can also lead to working in other global cannabis markets like Canada, which was the first country to fully legalize cannabis.
Some Canadian cannabis stocks have traded well in the sector due to it. Less fear of anyissues ot legal holds like the US market has faced. Yet in 2026, another wave is building; we very well could see another green rush for cannabis stock investors. More people are starting to see marijuana stocks as an investment opportunity of the future, not just as a fast way to make money.
From MSO to ancillary to pure-play marijuana stocks to buy, there are options for all investors and investment styles. For those who are active in the sector and watch the industry, see another shift happening, which will determine a lot for operators. Once there is a solid foundation set up with better laws, regulations, and better tax structures, it will be big for those who invest and operate the companies. Below are some top marijuana stocks to watch for better picks in the sector today.
Top Marijuana Stocks For 2026
- Ayr Wellness Inc. (OTC:AYRWF)
- Cresco Labs Inc. (OTC:CRLBF)
- FLUENT Corp. (OTC:CNTMF)
Ayr Wellness Inc.
Ayr Wellness Inc. cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods in the United States. On April 10th, the company announced the initial closing of the transfer of its Virginia operations into Arboretum Virginia LLC. Along with the closing and initial funding of its new money exit facility with Arboretum. 
This is in connection with the Company’s previously announced restructuring transactions. Arboretum is the entity established by the Company’s senior secured noteholders as the designated purchaser under the Master Purchase Agreement.
Cresco Labs Inc.
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. In more recent news, the company gave an update on its Texas license, which was just awarded to Cresco by the Texas Department of Public Safety. 
Under the corrected tabulation, the conditional license previously awarded has been rescinded, and Cresco Labs Texas, LLC has been placed on the TCUP eligibility list. Cresco Labs maintains that its application merits a conditional license, as originally determined by DPS. As well as evaluating its options to work with the state to protect that determination.
[Read More] Top Canadian Cannabis Penny Stocks to Watch This Month
FLUENT Corp.
FLUENT Corp., through its subsidiaries, cultivates, manufactures, processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas. At the start of May, the company announced it had entered into a definitive agreement to sell its Texas business. 
The definitive agreement is with Legacy Therapeutics, LLC, pursuant to which Legacy will acquire 100% of the issued and outstanding equity interests in Cansortium Texas, LLC.
[Read More] Top Marijuana Companies Building Momentum In 2026
Words From The CEO
David E. Vautrin, Interim Chief Executive Officer of FLUENT, said, “We are excited to see how Legacy, under Randy’s leadership, will leverage its deep pharmaceutical expertise and strong operational discipline to drive growth in the cannabis sector and expand the Texas market from our established base.”
